| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |